BIEX SALEST SALIVARY ESTRIOL TEST APPROVABLE FOR USE AS ADJUNCTIVE TOOL IN IDENTIFYING WOMEN AT RISK FOR PRETERM LABOR AND DELIVERY, PANEL SAYS
This article was originally published in The Gray Sheet
Executive Summary
Biex' SalEst salivary estriol test is approvable for use as an adjunctive tool in identifying women at risk for preterm labor and delivery, FDA's Clinical Chemistry and Clinical Toxicology Panel concluded at a Dec. 10 meeting in Rockville, Maryland.